Tue, Sep 23, 2014, 3:39 PM EDT - U.S. Markets close in 21 mins.

Recent

% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • raysfrom98 raysfrom98 Jun 12, 2013 10:12 AM Flag

    Todays news will be followed by a new round of institutional buying.

    IMO , so get in while its cheap.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 8:06AM Trius Therapeutics announces publication of antibiotic safety study in antimicrobial agents and chemotherapy; results suggest no clinically significant interactions between co's experimental antibiotic tedizolid and a commonly used class of medications (TSRX) 8.74 : Co announced the publication of the results of multiple clinical and animal studies showing the company's experimental antibiotic, tedizolid phosphate (TR-701), does not interact with monamine oxidase. MAO is an enzyme involved in the regulation of neurotransmitters such as serotonin, norepinephrine and dopamine, and its inhibition can lead to serious drug-drug interactions. These results were published in the July 2013 print issue of Antimicrobial Agents and Chemotherapy

 
TSRX
13.63-0.05(-0.37%)Sep 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.